Edap Tms (NASDAQ:EDAP) Cut to Sell at Wall Street Zen

Edap Tms (NASDAQ:EDAP) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a report on Monday, December 29th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Edap Tms currently has an average rating of “Reduce” and a consensus target price of $2.00.

Edap Tms Stock Performance

Shares of Edap Tms stock opened at $3.73 on Friday. The firm has a market capitalization of $139.46 million, a P/E ratio of -4.84 and a beta of -0.19. The company has a quick ratio of 0.97, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The company has a 50 day moving average price of $4.21 and a 200 day moving average price of $3.16. Edap Tms has a 52 week low of $1.21 and a 52 week high of $5.05.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Wednesday, March 25th. The medical equipment provider reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.09). Edap Tms had a negative return on equity of 100.07% and a negative net margin of 41.24%.The company had revenue of $22.22 million for the quarter, compared to analysts’ expectations of $21.28 million. Sell-side analysts expect that Edap Tms will post -0.6 EPS for the current year.

Institutional Trading of Edap Tms

Large investors have recently made changes to their positions in the company. Financial Planning Navigators CORP purchased a new stake in shares of Edap Tms during the fourth quarter worth $33,000. Leonteq Securities AG acquired a new stake in Edap Tms during the fourth quarter worth $313,000. Kovack Advisors Inc. purchased a new stake in Edap Tms in the 4th quarter valued at about $53,000. Rock Springs Capital Management LP raised its stake in shares of Edap Tms by 1.3% in the 4th quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the medical equipment provider’s stock valued at $4,233,000 after acquiring an additional 16,500 shares during the period. Finally, Flax Pond Capital LLC purchased a new stake in Edap Tms in the fourth quarter valued at approximately $2,623,000. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.